Related Experiment Video
Updated: Aug 5, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Fibrosis and Perinatal Features Correlated with Telomere Shortening in Pediatric Metabolic Dysfunction-Associated
Maria Rita Braghini1, Salvatore Daniele Bianco2, Marzia Bianchi1
1Research Unit of Genetics of Complex Phenotypes, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
Insights
Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to shorter telomere length (TL). Shorter TL correlates with advanced liver disease and fibrosis, suggesting telomere dynamics may influence pediatric MASLD progression.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Genetics
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising in children.
- Telomere maintenance dysregulation is a suspected driver of MASLD progression, but pediatric data is scarce.
Purpose of the Study:
- To examine the association between telomere length (TL) and hepato-metabolic characteristics in pediatric MASLD patients.
- To investigate the relationship between TL, disease severity, and perinatal factors in children with MASLD.
Main Methods:
- Quantitative PCR to measure leukocyte (LTL) and liver tissue (HTL) telomere length.
- Assessed telomerase reverse transcriptase (TERT) mRNA and protein expression.
- Analyzed associations between TL and clinical, metabolic, and perinatal variables in 212 pediatric MASLD patients and 40 controls.
Main Results:
- Children with MASLD exhibited significantly shorter LTL and HTL compared to controls.
- Shorter LTL was associated with advanced non-alcoholic steatohepatitis (MASH) and liver fibrosis.
- Reduced TERT expression was noted in MASLD patients, and LTL correlated with perinatal factors like preterm birth and low birthweight.
Conclusions:
- Leukocyte telomere length is significantly associated with disease severity, particularly fibrosis, in pediatric MASLD.
- Findings suggest a role for telomere dynamics in pediatric MASLD progression, warranting further longitudinal investigation.
- Shorter LTL independently correlated with MASH, fibrosis, and small-for-gestational-age status.
Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasingly prevalent condition in both adults and children. Dysregulated telomere maintenance has been proposed as a mechanism underlying disease progression, although pediatric evidence remains limited and controversial. This study aimed to investigate the relationship between telomere length (TL) and hepato-metabolic features in children with MASLD. A total of 212 pediatric patients with biopsy-proven MASLD and 40 controls were enrolled. Telomere length in leukocytes (LTL) and liver tissue (HTL) was measured using quantitative polymerase chain reaction, and telomerase reverse transcriptase (TERT) mRNA and protein expression were also evaluated. Associations between TL and clinical, metabolic, and perinatal variables were analyzed. Children with MASLD showed significantly shorter LTL and HTL compared to controls. Shorter LTL was observed in more advanced steatohepatitis (MASH) and was associated with fibrosis severity. TERT expression was reduced in patients. LTL was also associated with perinatal factors, including preterm birth and low birthweight. Multivariable analysis identified MASH, fibrosis, and small-for-gestational-age status as independently associated with shorter LTL. In conclusion, LTL is associated with disease severity in pediatric MASLD, particularly fibrosis. These findings support a potential role of telomere dynamics in disease progression, although causal relationships require confirmation in longitudinal studies.
Related Concept Videos
Cirrhosis II: Pathophysiology
Inborn Errors of Metabolism
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

